Hormone interference in metastatic breast cancer patients treated with medroxyprogesterone acetate at massive doses: preliminary results.
Sala
G
G
Castegnaro
E
E
Lenaz
G R
GR
Martoni
A
A
Piana
E
E
Pannuti
F
F
D001695:Biology; D001943:Breast Neoplasms; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D004194:Disease; D004703:Endocrine System; D005193:Family Planning Services; D005640:Follicle Stimulating Hormone; D006728:Hormones; D007986:Luteinizing Hormone; D017258:Medroxyprogesterone Acetate; D009369:Neoplasms; D010827:Physiology; D011388:Prolactin
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D006728:Hormones; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D017258:Medroxyprogesterone Acetate
Biology; Breast Cancer; Cancer; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents--administraction and dosage; Diseases; Endocrine System; Family Planning; Follicle Stimulating Hormone; Hormones; Luteinizing Hormone; Medroxyprogesterone Acetate--administraction and dosage; Neoplasms; Physiology; Prolactin